Use of growth hormone in children

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 5, 2006, Pages 260-268

  Hindmarsh, Peter C ^a,c,d   Dattani, Mehul T ^b,c  

^a Department of Paediatric Endocrinology ^*  (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Efficacy; Growth; Growth hormone deficiency; Safety; Somatropin

Indexed keywords

GLUCOCORTICOID; RECOMBINANT GROWTH HORMONE;

ACUTE PANCREATITIS; BODY HEIGHT; CARPAL TUNNEL SYNDROME; CHILD; CHRONIC KIDNEY FAILURE; COLON CANCER; COST BENEFIT ANALYSIS; DRUG APPROVAL; DRUG SAFETY; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; GYNECOMASTIA; HODGKIN DISEASE; HUMAN; INTRACRANIAL HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PIGMENTED NEVUS; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; SCOLIOSIS; SHORT STATURE; SIDE EFFECT; TURNER SYNDROME; UPPER RESPIRATORY TRACT OBSTRUCTION;

BODY HEIGHT; CHILD; DWARFISM, PITUITARY; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; RECOMBINANT PROTEINS; TURNER SYNDROME;

EID: 33646577162     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0169     Document Type: Review

References (53)

1. Raben MS (1958) Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 18: 901-903
2. Prader A et al. (1967) Long term treatment with human growth hormone (Raben) in small doses. Evaluation of 18 hypopituitary patients. Helv Paediatr Acta 22: 423-439
3. Tanner JM et al. (1971) Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children with growth hormone deficiency, low birth weight, inherited smallness, Turner syndrome and other complaints. Arch Dis Child 45: 745-779
4. GH Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85: 3990-3993
5. Dattani MT and Preece MA (2004) Growth hormone deficiency and related disorders: insights into causation, diagnosis and treatment. Lancet 363: 1977-1987
6. Wit JM et al. (1996) Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 39: 295-302
7. Tanaka T et al. (2002) Diagnosis and management of growth hormone deficiency in childhood and adolescence: part 2 - growth hormone treatment in growth hormone deficient children. Growth Horm IGF Res 12: 323-341
8. Saenger P (2002) Growth hormone in growth hormone deficiency. BMJ 325: 58-59
9. Preece MA et al. (1976) Dose dependence of growth response to human growth hormone in growth hormone deficiency. J Clin Endocrinol Metab 42: 477-483
10. Cohen P et al. (2002) Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 87: 90-98
11. Radetti G et al. (2003) Treatment of GH-deficient children with two different GH doses: effect on final height and cost-benefit implications. Eur J Endocrinol 148: 515-518
12. Ranke MB et al. (1994) Prediction of growth in response to treatment with growth hormone. In Progress in Growth Hormone Therapy - 5 Years of KIGS, 97-111 (Eds Ranke MB and Gunnarsson R) Mannheim: JJ Verlag
13. Burns EC et al. (1981) Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr 137: 155-164
14. Blethen SL et al. (1993) Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. J Clin Endocrinol Metab 74: 574-579
15. Adan L et al. (1997) Adult height in 24 patients treated for growth hormone deficiency and early puberty. J Clin Endocrinol Metab 82: 229-233
16. Mericq MV et al. (2000) Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab 85: 569-573
17. Tanaka T et al. (1997) GH and GnRH analog treatment in children who enter puberty at short stature. J Pediatr Endocrinol Metab 10: 623-628
18. Mul D et al. (2005) Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone. Clin Endocrinol 63: 185-190
19. Clayton PE et al. (2005) Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 152: 165-170
20. Salomon F et al. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321: 1797-1803
21. Tomlinson JW et al. (2001) Association between premature mortality and hypopituitarism: West Midlands Prospective Hypopituitary Study Group. Lancet 357: 425-431
22. Yuen KCJ et al. (2005) Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Clin Endocrinol 63: 428-436
23. Saenger P et al. (2001) Recommendations for the diagnosis and treatment of Turner syndrome. J Clin Endocrinol Metab 86: 3061-3069
24. van Pareren YK et al. (2003) Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88: 1119-1125
25. Stephure K et al. (2005) Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90: 3360-3366
26. Vimalachandra D et al. (2001) Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. J Pediatr 139: 560-567
27. Paterson WF and Donaldson MD (2003) Growth hormone therapy in the Prader-Willi syndrome. Arch Dis Child 88: 283-285
28. Myers SE et al. (2000) Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 137: 42-49
29. Carrel AL et al. (2004) Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J Pediatr 145: 744-749
30. von Pareren Y et al. (2003) Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double blind, dose-response GH trial. J Clin Endocrinlon Metab 88: 3584-3590
31. Ranke MB (1996) Towards a consensus on the definition of idiopathic short stature. Horm Res 45 (Suppl 2): 64-66
32. Leschek EW et al. (2004) Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 89: 3140-3148
33. Wit JM et al. (2005) Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146: 45-53
34. Finkelstein BS et al. (2002) Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 156: 230-240
35. Ulph F et al. (2004) Personality functioning: the influence of stature. Arch Dis Child 89: 17-21
36. Sandberg DE and Voss LD (2002) The psychosocial consequences of short stature: a review of the evidence. Best Pract Res Clin Endocrinol Metab 16: 449-463
37. Lai KYC et al. (1994) Cognitive abilities associated with Silver-Russell syndrome. Arch Dis Child 71: 490-496
38. Skuse DH et al. (1997) Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387: 705-708
39. Takala J et al. (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341: 785-792
40. Cutfield WS et al. (2000) Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 355: 610-613
41. Rivkees SA et al. (1994) Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure. J Pediatr 125: 322-325
42. Toogood AA et al. (2000) Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. J Clin Endocrinol Metab 85: 1727-1730
43. Moore JS et al. (1999) Modulation of 11β-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab 84: 4172-41774
44. Watanabe S et al. (1989) Risk factors for leukemia occurrence among growth hormone users. Jpn J Cancer Res 80: 822-825
45. Blethen SL et al. (1996) Safety of recombinant DNA-derived growth hormone (rhGH): the National Cooperative Growth Study experience. J Clin Endocrinol Metab 81: 1704-1710
46. Swerdlow AJ et al. (2002) Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-1985: a cohort study. Lancet 360: 273-277
47. Furstenberger G and Senn HJ (2002) Insulin-like growth factors and cancer. Lancet Oncol 5: 298-302
48. Gravholt CH (2005) Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab 1: 41-52
49. Allen DB (1999) Issues in the transition from childhood to adult growth hormone therapy. Pediatrics 104: 1004-1010
50. Donaubauer J et al. (2003) Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. Clin Endocrinol (Oxf) 58: 456-463
51. Mullis PE et al. (2005) Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up study. J Clin Endocrinol Metab 90: 2089-2096
52. Saggese G et al. (1998) Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998. Horm Res 50: 320-340
53. Shalet SM et al. (1998) The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 19: 203-223